Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal By: TalkMarkets January 17, 2018 at 12:59 PM EST Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene. Read More >> Related Stocks: Bellicum Pharmaceuticals Inc Bluebird Bio Celgene Corp Cellectis S.A. ADR Gilead Sciences